Criteria for Minimal Manifestations in Myasthenia Gravis Patients
Author Information
Author(s): Watanabe Genya, Takai Yoshiki, Nagane Yuriko, Kubota Tomoya, Yasuda Manato, Akamine Hiroyuki, Onishi Yosuke, Uzawa Akiyuki, Kawaguchi Naoki, Masuda Masayuki, Konno Shingo, Amino Itaru, Minami Naoya, Kimura Takashi, Samukawa Makoto, Sugimoto Takamichi, Suzuki Yasushi, Takahashi Masanori P., Suzuki Shigeaki, Murai Hiroyuki, Aoki Masashi, Utsugisawa Kimiaki
Primary Institution: National Hospital Organization Sendai Medical Center
Hypothesis
Can objective criteria for minimal manifestations or better status in generalized myasthenia gravis patients be established using severity metrics?
Conclusion
The study proposes specific cutoff values for determining minimal manifestations in generalized myasthenia gravis patients, which could enhance clinical trial rigor and patient care.
Supporting Evidence
- Cutoff values for strict MM-or-better were MG-ADL ≤2, QMG ≤7, and MGC ≤4.
- Sensitivity and specificity for MG-ADL cutoff were 82.0% and 85.0%, respectively.
- Patients classified as strict MM-or-better had significantly lower severity scores than those classified as optimistic MM-or-better.
- Quantitative criteria for MM-or-better can aid in clinical trials and patient evaluations.
- Data were collected from a large cohort of 2784 patients across multiple surveys.
- Statistical analyses included Mann–Whitney U tests and ROC curves to determine cutoff values.
- Mean values of the revised MG quality of life scale were significantly lower in the strict MM-or-better group.
Takeaway
Doctors want to help myasthenia gravis patients feel better, so they looked at a lot of patients to find clear rules for what 'feeling better' means.
Methodology
The study analyzed data from 2784 generalized myasthenia gravis patients using severity metrics from nationwide surveys.
Potential Biases
Potential bias from overlapping patient data across multiple surveys.
Limitations
The study is retrospective and cross-sectional, and lacks QMG score data from 2021.
Participant Demographics
Patients included both males and females, with a mean age of approximately 58 years.
Statistical Information
P-Value
<0.0001
Confidence Interval
95% CI reported for AUC values
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website